Literature DB >> 31541476

Management with secukinumab of tumour necrosis factor inhibitor-induced pulmonary sarcoidosis-like reaction in a patient with psoriasis.

G Eichhoff1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31541476     DOI: 10.1111/ced.14101

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


× No keyword cloud information.
  3 in total

Review 1.  The Evolving Landscape of Cutaneous Sarcoidosis: Pathogenic Insight, Clinical Challenges, and New Frontiers in Therapy.

Authors:  Julie H Wu; Sotonye Imadojemu; Avrom S Caplan
Journal:  Am J Clin Dermatol       Date:  2022-05-18       Impact factor: 6.233

Review 2.  Emerging Molecular Targets for the Treatment of Refractory Sarcoidosis.

Authors:  Gonçalo Boleto; Matheus Vieira; Anne Claire Desbois; David Saadoun; Patrice Cacoub
Journal:  Front Med (Lausanne)       Date:  2020-11-24

3.  Sarcoidosis manifesting during treatment with secukinumab for psoriatic arthritis.

Authors:  Colm Kirby; Darragh Herlihy; Lindsey Clarke; Ronan Mullan
Journal:  BMJ Case Rep       Date:  2021-02-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.